As promised here is the post on globalization, one of the three major trends driving the biotechnology industry to reinvent itself, according to Ernst and Young 2008 biotechnology report. Pharma and biotech companies are taking advantage of the ‘flattenning world,’ as described by Colin Powel in his keynote speech, and jumping into the globalization trend [...]
Filed under: Convention, bio08 | Tagged: bioethics, Ernst & Young Biotechnology Report 2008, globilization, NASA | 1 Comment »
“For Vertex, this year’s BIO convention provided an excellent opportunity to
both network and establish new relationships with hundreds of biotech
leaders from around the globe. The convention is ‘the’ place where these
interactions can take place on such a large scale and San Diego was a great
location for these groups to convene.”
–Representative of Vertex Pharmaceuticals Incorporated
Filed under: Uncategorized | No Comments »
“We use the language of life to fix its mistakes. We use the language of life to enable us to live on this planet sustainably. Decoding the secrets of life scares some people, but it inspires us. Some people ask how can you play God with the language of life? We say [...]
Filed under: Uncategorized | No Comments »
A number of breakout sessions today focused on biomarkers and personalized medicine. A very compelling session was on Biomarkers and Diagnostics in Alzheimer’s. It my impression that one of the major hurdles in the adoption of biomarker technology is the conception that its simply “diagnostics.” The current system is designed to reimburse based on the [...]
Filed under: BIO, Healthcare, bio08 | Tagged: Alzheimer's, biomarkers | No Comments »
The Bio International Convention hosted a fantastic panel today on the 2008 Ernst & Young global biotechnology report. The industry is at “the start of a revolution” and aiming to reinvent itself because of three trends, shared moderator Glen Giovannetti of Ernst & Young, (1) R&D productivity, (2) personalized medicine, and (3) globalization. This post [...]
Filed under: Convention, bio08 | Tagged: biotechnology, bioethics, ernst & young global biotechnology report 2008, diagnostic medicine, personalized medicine | 1 Comment »
The idea of the de-differentiation of mature cells into stem cells has captivated the community for the past two years since its initial publication. Is it possible to use these induced pluripotent stem cells (iPS cells) instead of the embryonic stem cells which have garnered so much controversy? The Regenerative Medicine session on Cell De-Differentiation [...]
Filed under: BIO, bio08 | No Comments »
On the way out NHGRI director Francis Collins mentions that it will be very interesting to see how the recent actions of the state of California’s Health Department to send out cease and desist letters to personal genomics testing companies will play out. Who knows maybe Arnold Schwarzenegger will offer his insight tomorrow at the [...]
Filed under: BIO, bio08 | No Comments »
Sitting in amazement of the logistical tango displayed by the BIO organizers on just exactly how does one feed 20,000+ attendees in a sophisticated and elegant manner, needless to say the Keynote Luncheon #1 was executed to perfection. Whilst hacking away at a blog post my PC endured the dreaded blue screen of death. What’s [...]
Filed under: Uncategorized | No Comments »
The BIO International Convention will travel back East to Atlanta, Ga. in 2009. With the nation’s seventh-largest biotech cluster, Georgia is home to a number of life-science companies and research universities, as well as the Center for Disease Control and Prevention and the Carter Center for Global Health Initiatives. The state of Georgia is also [...]
Filed under: Uncategorized | No Comments »
While the economy may not be as robust as it has in recent years, there certainly was no sign of that at today’s Opening Luncheon. Jim Greenwood, our President & CEO welcomed attendees to the inaugural BIO National Venture Conference and cited these impressive stats:
140 top-level (VP and higher) venture capitalists – including 4 international investors – [...]
Filed under: national venture conference | Tagged: BIO, biotechnology, Biotechnology Industry Organization, national venture conference, nvc, venture funding | No Comments »
|
susanatbio
TKtraveler
nicoleatbio
ecreese
sourav123
Jennifer Miller
Darren Fast
christineross
arubenstein
patentbaristas
sdmimi
mikesgene
